Last updated: November 22, 2022
Sponsor: ADIR Association
Overall Status: Active - Recruiting
Phase
N/A
Condition
Lung Disease
Treatment
N/AClinical Study ID
NCT05372926
HighFlowMusc
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Cared for as part of a respiratory rehabilitation program (ADIR association)
- Presenting diffuse fibrosing interstitial pneumonitis, documented by CT scan data andwhatever its etiology
- Presenting severe hypoxemia in ambient air (SpO2<90%) during an exercise test (6-minute walk test or functional exercise test)
Exclusion
Exclusion Criteria:
- Patient with a contraindication to carrying out a respiratory rehabilitation program
- Patient having presented an exacerbation of PID, pneumothorax or pneumomediastinum inthe 3 months preceding potential inclusion
- Tracheostomized patient
- Patient with a contraindication to the placement of a nasogastric tube
- Pregnant or breastfeeding women or women of childbearing age without effective meansof contraception (a pregnancy test will be carried out)
- Protected adult patient (guardianship or curatorship)
- Patient deprived of liberty by court or administrative decision
- Refusal of patient participation or consent
Study Design
Total Participants: 16
Study Start date:
November 22, 2022
Estimated Completion Date:
November 23, 2024
Connect with a study center
ADIR association
Bois-Guillaume, 76230
FranceActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.